The Biotechnology Innovation Organization (BIO) will hold its first-ever BIO Clinical Trial Diversity Summit June 24-25, 2021 to focus on the need for greater health equity in clinical trials.

WHAT:   The BIO Clinical Trial Diversity Summit will bring together community organizations and stakeholders from across the clinical development spectrum to address racial inequities, learn from patient experts and help companies improve trials. The summit will culminate in the creation of a comprehensive vision for an equitable drug development ecosystem and transforming that vision into an actionable strategy to execute real change.

WHO:     Speakers include industry leaders, academics and health equity experts from across the field including:

• Dr. Michelle McMurry-Heath, MD, PhD, President and CEO of BIO
• Dr. Loretta Christensen, MD, MBA, MSJ, FACS, Chief Medical Officer, Navajo Area Indian Health Service
• Silas Buchanan, Co-founder and CEO, Institute for eHealth Equity
• Dr. Cartier Esham, PhD, Chief Scientific Officer, BIO
• Dr. Julie Gerberding, MD, Chief Patient Officer, Executive VP of Population Health, Global Policy, Merck
• David Coman, MBA, President and CEO of Science 37
• Dr. Merdad Parsey, MD, PhD, Chief Medical Officer, Gilead
• Dr. Elena V. Rios, MD, President and CEO, National Hispanic Medical Association, National Hispanic Health Foundation
• Dr. Darryl Sleep, MD, Chief Medical Officer, Amgen
• Ted W. Love, M.D., President and CEO, Global Blood Therapeutics
• Debra Fraser-Howze, Founder, Choose Healthy Life and Principal, D. Fraser Associates

WHEN:   June 24-25, 2021

              12:00-4:50 p.m. EST

WHERE: Virtual

Complimentary registration is available for media. Click here to create an account and register.